What's breaking now, across thousands of outlets.
Researchers at Trinity College Dublin, in collaboration with Breye Therapeutics, have found that an oral medication ("Danegaptide") can protect against vision-threatening damage in nonproliferative diabetic retinopathy (NPDR), a leading cause of blindness in working-age adults.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
A joint team of researchers at Bar-Ilan University and the Weizmann Institute has used advanced computational design methods to enhance the ability of genetically engineered immune cells to recognize…
A groundbreaking brain imaging study in awake rats reveals that the psychedelic mescaline uniquely alters brain function.
Shajila Siricilla, Ph.D., assistant professor of pediatrics, and Jennifer Herington, Ph.D., associate professor of pediatrics, led a team that systematically screened 1,191 FDA-approved drugs and…
Health tech company CertifyOS is launching a new national model for provider credentialing, with several major payers already on board as participants.
OXFORD, England — The world's first therapy designed to fix a patient's unique genetic mutation cost $1.65 million to make, a key facilitator of the project revealed Wednesday at a rare disease…
Former Ogun First Lady, Olufunso Amosun, has urged women not to see cancer as a death sentence, stressing that early detection and prompt treatment save li Read More…
